Cleared Traditional

imani i2Plus Breast Pump (K222573) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222573 · Imani Co. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
190d
Days
Class 2
Risk

K222573 is an FDA 510(k) clearance for the imani i2Plus Breast Pump. Classified as Pump, Breast, Powered (product code HGX), Class II - Special Controls.

Submitted by Imani Co. (Yongin-Si, CN). The FDA issued a Cleared decision on March 3, 2023 after a review of 190 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.5160 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Imani Co. devices

Submission Details

510(k) Number K222573 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 25, 2022
Decision Date March 03, 2023
Days to Decision 190 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
30d slower than avg
Panel avg: 160d · This submission: 190d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HGX Pump, Breast, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.5160
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Global Medical Standard Consulting Co., Ltd.
Kyung Jin Lee

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HGX Pump, Breast, Powered

All 127
Devices cleared under the same product code (HGX) and FDA review panel - the closest regulatory comparables to K222573.
ARDO Bellis
K230590 · Ardo Medical AG · Mar 2023
MilkMate Breast Pump
K223084 · Milkmate Products, Inc. · Mar 2023
Electric breast pump (model: M5)
K223693 · Shenzhen Lutejiacheng Technology Co., Ltd. · Mar 2023
Wearable Breast Pump (Model:YD-1193,YD-1195,YD-1196,YD-1198,YD-1199
K222782 · Zhejiang Carebao Co., Ltd. · Jan 2023
Wearable Breast Pump (Model S1DW)
K222045 · Shenzhen TPH Technology Co., Ltd. · Jan 2023
CIMILRE Free-T2 Plus
K221708 · Cimilre Co., Ltd. · Dec 2022